Please login to the form below

Not currently logged in
Email:
Password:

Cambridge, UK

This page shows the latest Cambridge, UK news and features for those working in and with pharma, biotech and healthcare.

Sanofi gains access to antibody tech with Kymab acquisition

Sanofi gains access to antibody tech with Kymab acquisition

Sanofi has made a $1.45bn play for Cambridge, UK-based Kymab, extending its reach into immunotherapy and immunology.

Latest news

More from news
Approximately 2 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • AI and accelerated computing ring in new era for healthcare AI and accelerated computing ring in new era for healthcare

    And pharmaceutical companies, including GlaxoSmithKline, and major healthcare systems, like the UK’s National Health Service (NHS), will harness technologies like the Cambridge-1 supercomputer – the UK’s fastest AI supercomputer –

  • AstraZeneca’s focus on diagnosing and managing chronic kidney disease AstraZeneca’s focus on diagnosing and managing chronic kidney disease

    AstraZeneca's R&D centre in Cambridge, UK. Moderate to severe chronic kidney disease (CKD) is an under-recognised public health emergency.

  • A snapshot of Healx A snapshot of Healx

    Healx is based in Cambridge, UK, a key European biotech hub, and was founded in 2014 by Dr Tim Guilliams, a biochemical engineer and founder of the Cambridge Rare Disease Network, ... That said, we share the concerns of a number of UK industry bodies and

  • A snapshot of Microbiotica A snapshot of Microbiotica

    Cambridge, UK-based Microbiotica is part of a new wave of pioneering firms focused on developing novel therapeutics based on the microbiome – the bacteria which live in the human body and ... of CMOs in the world who can do this work, with none in the

  • A snapshot of Crescendo Biologics A snapshot of Crescendo Biologics

    The company is based in Cambridge, UK, which is renowned for its antibody and biologics research and expertise, making it a prime location for Crescendo’s work. ... Cambridge, UK is probably the leading antibody and biologics development location in

More from intelligence
Approximately 2 fully matching, plus 15 partially matching documents found.

Latest appointments

  • F-star hires ex-BMS immuno-oncology leader

    New CMO to oversee development of lead candidate. UK biotech F-star has appointed Louis Kayitalire, MD, as its new Chief Medical Officer (CMO), wooing him from a senior role in ... F-star says this newly created management position will be crucial

  • New faces at BioStrata, P\S\L Group and FCB Health New faces at BioStrata, P\S\L Group and FCB Health

    All five new hires will be based out of the company’s UK headquarters in Cambridge. ... Rachael Young, inbound account executive and Sam Willstead, PR account executive, are both recent science graduates from the University of Cambridge and the

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    Congenica poaches AZ’s business performance director. Currently director of business performance at AstraZeneca, Wendy Britten (pictured) has decided to join Cambridge, UK-based Cogenica, a clinical genomics interpretation software provider.

  • BioStrata strengthens team with two new hires BioStrata strengthens team with two new hires

    James Reeve and Kat Steer join the marketing agency. Cambridge, UK-based life science agency has expanded their PR, social strategy and digital services team with the addition of two senior

  • Constellation Pharmaceuticals strengthens management team Constellation Pharmaceuticals strengthens management team

    Appointments include Adrian Senderowicz as chief medical officer. Cambridge, UK-based Constellation Pharmaceuticals has appointed Adrian Senderowicz as its senior vice president and chief medical officer.

More from appointments
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest from PMHub

  • Ashfield Healthcare Communications rebrands as Ashfield Health

    Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind Matter, a new global, data-driven creative communications agency. ... Formed through the merging of three successful Ashfield Health agencies – US-based

  • Zyme Communications

    Address:. Stirling House, Cambridge Innovation Park. Denny End Road, Waterbeach, Cambridge.

  • Moving away from pharma’s paternalistic approach

    12 September 2018, Cambridge, UK—The pharmaceutical industry has achieved great success in delivering innovative medicines, but life science companies must become ever more consumer-centric if they are to realise ... Any profits generated from book

  • Cogentia

    Cogentia is a market access and health economic consulting company based in Cambridge, UK. ... Address:. 16-20 Regent Street. Cambridge. CB2 1DB. United Kingdom.

  • Biocair

    Cambridge. CB1 3LX. UK.

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics